Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CILGAVIMAB\TIXAGEVIMAB Cause Therapy non-responder? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapy non-responder have been filed in association with CILGAVIMAB\TIXAGEVIMAB. This represents 0.2% of all adverse event reports for CILGAVIMAB\TIXAGEVIMAB.

5
Reports of Therapy non-responder with CILGAVIMAB\TIXAGEVIMAB
0.2%
of all CILGAVIMAB\TIXAGEVIMAB reports
1
Deaths
2
Hospitalizations

How Dangerous Is Therapy non-responder From CILGAVIMAB\TIXAGEVIMAB?

Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CILGAVIMAB\TIXAGEVIMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does CILGAVIMAB\TIXAGEVIMAB Cause?

Covid-19 (521) Drug ineffective (123) Product use issue (94) Fatigue (86) Headache (86) Dyspnoea (84) Pyrexia (81) Nausea (68) Dizziness (64) Breakthrough covid-19 (51)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which CILGAVIMAB\TIXAGEVIMAB Alternatives Have Lower Therapy non-responder Risk?

CILGAVIMAB\TIXAGEVIMAB vs CILOSTAZOL CILGAVIMAB\TIXAGEVIMAB vs CILTACABTAGENE AUTOLEUCEL CILGAVIMAB\TIXAGEVIMAB vs CIMETIDINE CILGAVIMAB\TIXAGEVIMAB vs CIMZIA CILGAVIMAB\TIXAGEVIMAB vs CINACALCET

Related Pages

CILGAVIMAB\TIXAGEVIMAB Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder CILGAVIMAB\TIXAGEVIMAB Demographics